Intrathecal antitoxin in the treatment of tetanus

Detalhes bibliográficos
Autor(a) principal: Levin, Anna Sara Shafferman
Data de Publicação: 1987
Outros Autores: Barone, Antonio Alci, Shiroma, Mario
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista do Instituto de Medicina Tropical de São Paulo
Texto Completo: https://www.revistas.usp.br/rimtsp/article/view/28529
Resumo: Tetanus is an important disease in underdeveloped countries. We present a review of literature concerning the use of intrathecal antitoxin in the treatment of tetanus. Historical aspects and the physiopathologic basis for this route of administration of antitoxin are brought up and the efficacy of the uses of heterologous and homologous antitoxin associated or not to systemic antitoxin and steroids is discussed. A great number of clinical studies have been done and many aren't well controlled or conclusive. Others have conflicting results. Homologous antitoxin (TIG) was used by GUPTA 14, in slight cases of tetanus; DIOP-MAR et al5, in Senegal; and LIST22, in Austria, with a reduction of the mortality by the disease when of its intrathecal use. However, BOLOT et al34, in France; SEDAGHATIAN35, and VALKI et al 44,45,46, don't obtain favorable results with intrathecal TIG. The same controversy arises with the use of intrathecal heterologous antitoxin (SAT). GALLAIS et al 10,11,12; SINGH et al38; KESWANI et al21; SANDERS et al32, obtain significantly better results when compared to their control groups, NEEQUAYE et al23; THOMAS et al43; and BHANDARI et al², find no advantages to the use of this route. There are a number of factors possibly responsible for these differences in results: the intrathecal or systemic use of steroids; the use of homologous or heterologous antitoxin; their dosage and route of administration. The adverse effects due to intrathecal antitoxin are in general slight, however this route of administration should be considered experimental until there is further evidence of its benefit.
id IMT-1_967af10b26ffc33f9eb13fc848b2ec2e
oai_identifier_str oai:revistas.usp.br:article/28529
network_acronym_str IMT-1
network_name_str Revista do Instituto de Medicina Tropical de São Paulo
repository_id_str
spelling Intrathecal antitoxin in the treatment of tetanus Soroterapia intratecal no tétano. Revisão Tétano^i1^sterapêutAntitoxina tetânica^i1^sAdministração intrateUso terapêutico^i1^sAdministração e dosa Tetanus is an important disease in underdeveloped countries. We present a review of literature concerning the use of intrathecal antitoxin in the treatment of tetanus. Historical aspects and the physiopathologic basis for this route of administration of antitoxin are brought up and the efficacy of the uses of heterologous and homologous antitoxin associated or not to systemic antitoxin and steroids is discussed. A great number of clinical studies have been done and many aren't well controlled or conclusive. Others have conflicting results. Homologous antitoxin (TIG) was used by GUPTA 14, in slight cases of tetanus; DIOP-MAR et al5, in Senegal; and LIST22, in Austria, with a reduction of the mortality by the disease when of its intrathecal use. However, BOLOT et al34, in France; SEDAGHATIAN35, and VALKI et al 44,45,46, don't obtain favorable results with intrathecal TIG. The same controversy arises with the use of intrathecal heterologous antitoxin (SAT). GALLAIS et al 10,11,12; SINGH et al38; KESWANI et al21; SANDERS et al32, obtain significantly better results when compared to their control groups, NEEQUAYE et al23; THOMAS et al43; and BHANDARI et al², find no advantages to the use of this route. There are a number of factors possibly responsible for these differences in results: the intrathecal or systemic use of steroids; the use of homologous or heterologous antitoxin; their dosage and route of administration. The adverse effects due to intrathecal antitoxin are in general slight, however this route of administration should be considered experimental until there is further evidence of its benefit. Devido à importância do tétano nos países em desenvolvimento, foi feita uma revisão da literatura recente abordando aspectos históricos e bases fisio-patológicas do uso da soroterapia intratecal no tratamento do tétano. Discute-se principalmente a eficácia dessa terapêutica envolvendo o uso da antitoxina heteróloga e homóloga, associada ou não à antitoxina e a corticosteróides por via sistêmica. São abordadas também as complicações do uso da antitoxina por via intrarraquideana que são, em geral, leves e transitórias. As tentativas de introduzir definitivamente a administração intratecal da antitoxina tetânica, na terapêutica do tétano, são precoces, uma vez que estudos existentes até o momento tem resultados contraditórios e muitas variáveis envolvidas. Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo1987-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rimtsp/article/view/28529Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 No. 5 (1987); 255-267 Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 Núm. 5 (1987); 255-267 Revista do Instituto de Medicina Tropical de São Paulo; v. 29 n. 5 (1987); 255-267 1678-99460036-4665reponame:Revista do Instituto de Medicina Tropical de São Pauloinstname:Instituto de Medicina Tropical (IMT)instacron:IMTporhttps://www.revistas.usp.br/rimtsp/article/view/28529/30382Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Pauloinfo:eu-repo/semantics/openAccessLevin, Anna Sara ShaffermanBarone, Antonio AlciShiroma, Mario2012-07-02T00:57:49Zoai:revistas.usp.br:article/28529Revistahttp://www.revistas.usp.br/rimtsp/indexPUBhttps://www.revistas.usp.br/rimtsp/oai||revimtsp@usp.br1678-99460036-4665opendoar:2022-12-13T16:50:15.666108Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)true
dc.title.none.fl_str_mv Intrathecal antitoxin in the treatment of tetanus
Soroterapia intratecal no tétano. Revisão
title Intrathecal antitoxin in the treatment of tetanus
spellingShingle Intrathecal antitoxin in the treatment of tetanus
Levin, Anna Sara Shafferman
Tétano^i1^sterapêut
Antitoxina tetânica^i1^sAdministração intrate
Uso terapêutico^i1^sAdministração e dosa
title_short Intrathecal antitoxin in the treatment of tetanus
title_full Intrathecal antitoxin in the treatment of tetanus
title_fullStr Intrathecal antitoxin in the treatment of tetanus
title_full_unstemmed Intrathecal antitoxin in the treatment of tetanus
title_sort Intrathecal antitoxin in the treatment of tetanus
author Levin, Anna Sara Shafferman
author_facet Levin, Anna Sara Shafferman
Barone, Antonio Alci
Shiroma, Mario
author_role author
author2 Barone, Antonio Alci
Shiroma, Mario
author2_role author
author
dc.contributor.author.fl_str_mv Levin, Anna Sara Shafferman
Barone, Antonio Alci
Shiroma, Mario
dc.subject.por.fl_str_mv Tétano^i1^sterapêut
Antitoxina tetânica^i1^sAdministração intrate
Uso terapêutico^i1^sAdministração e dosa
topic Tétano^i1^sterapêut
Antitoxina tetânica^i1^sAdministração intrate
Uso terapêutico^i1^sAdministração e dosa
description Tetanus is an important disease in underdeveloped countries. We present a review of literature concerning the use of intrathecal antitoxin in the treatment of tetanus. Historical aspects and the physiopathologic basis for this route of administration of antitoxin are brought up and the efficacy of the uses of heterologous and homologous antitoxin associated or not to systemic antitoxin and steroids is discussed. A great number of clinical studies have been done and many aren't well controlled or conclusive. Others have conflicting results. Homologous antitoxin (TIG) was used by GUPTA 14, in slight cases of tetanus; DIOP-MAR et al5, in Senegal; and LIST22, in Austria, with a reduction of the mortality by the disease when of its intrathecal use. However, BOLOT et al34, in France; SEDAGHATIAN35, and VALKI et al 44,45,46, don't obtain favorable results with intrathecal TIG. The same controversy arises with the use of intrathecal heterologous antitoxin (SAT). GALLAIS et al 10,11,12; SINGH et al38; KESWANI et al21; SANDERS et al32, obtain significantly better results when compared to their control groups, NEEQUAYE et al23; THOMAS et al43; and BHANDARI et al², find no advantages to the use of this route. There are a number of factors possibly responsible for these differences in results: the intrathecal or systemic use of steroids; the use of homologous or heterologous antitoxin; their dosage and route of administration. The adverse effects due to intrathecal antitoxin are in general slight, however this route of administration should be considered experimental until there is further evidence of its benefit.
publishDate 1987
dc.date.none.fl_str_mv 1987-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/28529
url https://www.revistas.usp.br/rimtsp/article/view/28529
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/28529/30382
dc.rights.driver.fl_str_mv Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
dc.source.none.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 No. 5 (1987); 255-267
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 Núm. 5 (1987); 255-267
Revista do Instituto de Medicina Tropical de São Paulo; v. 29 n. 5 (1987); 255-267
1678-9946
0036-4665
reponame:Revista do Instituto de Medicina Tropical de São Paulo
instname:Instituto de Medicina Tropical (IMT)
instacron:IMT
instname_str Instituto de Medicina Tropical (IMT)
instacron_str IMT
institution IMT
reponame_str Revista do Instituto de Medicina Tropical de São Paulo
collection Revista do Instituto de Medicina Tropical de São Paulo
repository.name.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)
repository.mail.fl_str_mv ||revimtsp@usp.br
_version_ 1798951637215084544